Epidemiology

You have full text access to this OnlineOpen article

Organochlorines and risk of non-Hodgkin lymphoma

  1. John J. Spinelli1,†,*,
  2. Carmen H. Ng1,
  3. Jean-Philippe Weber2,
  4. Joseph M. Connors1,
  5. Randy D. Gascoyne1,
  6. Agnes S. Lai1,
  7. Angela R. Brooks-Wilson1,
  8. Nhu D. Le1,
  9. Brian R. Berry1,
  10. Richard P. Gallagher1

Article first published online: 23 AUG 2007

DOI: 10.1002/ijc.23005

Issue

International Journal of Cancer

International Journal of Cancer

Volume 121, Issue 12, pages 2767–2775, 15 December 2007

Additional Information

How to Cite

Spinelli, J. J., Ng, C. H., Weber, J.-P., Connors, J. M., Gascoyne, R. D., Lai, A. S., Brooks-Wilson, A. R., Le, N. D., Berry, B. R. and Gallagher, R. P. (2007), Organochlorines and risk of non-Hodgkin lymphoma. Int. J. Cancer, 121: 2767–2775. doi: 10.1002/ijc.23005

Author Information

  1. 1

    BC Cancer Agency, Vancouver, British Columbia, Canada

  2. 2

    Centre de Toxicologie du Québec, Sainte-Foy, Québec

  1. †

    Fax: +604-675-8180.

*BC Cancer Agency, 675 W. 10th Avenue, Vancouver, British Columbia, V5Z 1L3 Canada

Publication History

  1. Issue published online: 22 OCT 2007
  2. Article first published online: 23 AUG 2007
  3. Manuscript Accepted: 1 JUN 2007
  4. Manuscript Received: 19 FEB 2007

Funded by

  • Canadian Cancer Society through the National Cancer Institute of Canada
  • Canadian Institutes of Health Research
  • Michael Smith Foundation for Health Research

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (114K)

References

  • 1
    RiesLAG, MelbertD, KrapchoM, MariottoA, MillerBA, FeuerEJ, CleggL, HornerMJ, HowladerN, EisnerMP, ReichmanM, EdwardsBK (eds). SEER Cancer Statistics Review, 1975–2004, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2004/, based on November 2006 SEER data submission, posted to the SEER web site, 2007.
  • 2
    Sandin S, Hjalgrim H, Glimelius B, Rostgaard K, Pukkala E, Askling J. Incidence of non-Hodgkin's lymphoma in Sweden, Denmark, and Finland from 1960 through 2003: an epidemic that was. Cancer Epidemiol Biomarkers Prev 2006; 15: 1295–300.
  • 3
    Dreiher J, Kordysh E. Non-Hodgkin lymphoma and pesticide exposure: 25 years of research. Acta Haematol 2006; 116: 153–64.
  • 4
    Engel LS, Lan Q, Rothman N. Polychlorinated biphenyls and non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 2007; 16: 373–6.
  • 5
    Cantor KP, Strickland PT, Brock JW, Bush D, Helzlsouer K, Needham LL, Zahm SH, Comstock GW, Rothman N. Risk of non-Hodgkin's lymphoma and prediagnostic serum organochlorines: β-hexachlorocyclohexane, chlordane/heptachlor-related compounds, dieldrin, and hexachlorobenzene. Environ Health Perspect 2003; 111: 179–83.
  • 6
    De Roos AJ, Hartge P, Lubin JH, Colt JS, Davis S, Cerhan JR, Severson RK, Cozen W, Patterson DG,Jr, Needham LL, Rothman N. Persistent organochlorine chemicals in plasma and risk of non-Hodgkin's lymphoma. Cancer Res 2005; 65: 11214–26.
  • 7
    Hardell L, Eriksson M, Lindstrom G, Van Bavel B, Linde A, Carlberg M, Liljegren G. Case-control study on concentrations of organohalogen compounds and titers of antibodies to Epstein-Barr virus antigens in the etiology of non-Hodgkin lymphoma. Leuk Lymphoma 2001; 42: 619–29.
  • 8
    Rothman N, Cantor KP, Blair A, Bush D, Brock JW, Helzlsouer K, Zahm SH, Needham LL, Pearson GR, Hoover RN, Comstock GW, Strickland PT. A nested case-control study of non-Hodgkin lymphoma and serum organochlorine residues. Lancet 1997; 350: 240–4.
  • 9
    Hardell L, Liljegren G, Lindstrom G, Van Bavel B, Broman K, Fredrikson M, Hagberg H, Nordstrom M, Johansson B. Increased concentrations of chlordane in adipose tissue from non-Hodgkin's lymphoma patients compared with controls without a malignant disease. Int J Oncol 1996; 9: 1139–42.
  • 10
    Hardell L, Van Bavel B, Lindstrom G, Fredrikson M, Hagberg H, Liljegren G, Nordstrom M, Johansson B. Higher concentrations of specific polychlorinated biphenyl congeners in adipose tissue from non-Hodgkin's lymphoma patients compared with controls without a malignant disease. Int J Oncol 1996; 9: 603–8.
  • 11
    Quintana PJ, Delfino RJ, Korrick S, Ziogas A, Kutz FW, Jones EL, Laden F, Garshick E. Adipose tissue levels of organochlorine pesticides and polychlorinated biphenyls and risk of non-Hodgkin's lymphoma. Environ Health Perspect 2004; 112: 854–61.
  • 12
    Jaffe ES, Harris NL, Stein H, Vardiman JW. World Health Organization classification of tumours: pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon, France: IARC Press, 2001.
  • 13
    Baris D, Kwak LW, Rothman N, Wilson W, Manns A, Tarone RE, Hartge P. Blood levels of organochlorines before and after chemotherapy among non-Hodgkin's lymphoma patients. Cancer Epidemiol Biomarkers Prev 2000; 9: 193–7.
  • 14
    Chevrier J, Dewailly E, Ayotte P, Mauriege P, Despres JP, Tremblay A. Body weight loss increases plasma and adipose tissue concentrations of potentially toxic pollutants in obese individuals. Int J Obes Relat Metab Disord 2000; 24: 1272–8.
  • 15
    Patterson DG,Jr, Isaacs SG, Alexander LR, Turner WE, Hampton L, Bernert JT, Needham LL. Determination of specific polychlorinated dibenzo-p-dioxins and dibenzofurans in blood and adipose tissue by isotope dilution-high-resolution mass spectrometry. IARC Sci Publ 1991; 108: 299–342.
  • 16
    Hornung R, Reed L. Estimation of average concentration in the presence of nondetectable values. Appl Occup Environ Hyg 1990; 5: 46–51.
  • 17
    Van den Berg M, Birnbaum L, Bosveld AT, Brunstrom B, Cook P, Feeley M, Giesy JP, Hanberg A, Hasegawa R, Kennedy SW, Kubiak T, Larsen JC, et al. Toxic equivalency factors (TEFs) for PCBs, PCDDs, PCDFs for humans and wildlife. Environ Health Perspect 1998; 106: 775–92.
  • 18
    Begg CB, Zhang ZF. Statistical analysis of molecular epidemiology studies employing case-series. Cancer Epidemiol Biomarkers Prev 1994; 3: 173–5.
  • 19
    Dubin N, Pasternack BS. Risk assessment for case-control subgroups by polychotomous logistic regression. Am J Epidemiol 1986; 123: 1101–17.
  • 20
    Rusiecki JA, Matthews A, Sturgeon S, Sinha R, Pellizzari E, Zheng T, Baris D. A correlation study of organochlorine levels in serum, breast adipose tissue, and gluteal adipose tissue among breast cancer cases in India. Cancer Epidemiol Biomarkers Prev 2005; 14: 1113–24.
  • 21
    Juan CY, Thomas GO, Sweetman AJ, Jones KC. An input–output balance study for PCBs in humans. Environ Int 2002; 28: 203–14.
  • 22
    Wolff MS, Britton JA, Teitelbaum SL, Eng S, Deych E, Ireland K, Liu Z, Neugut AI, Santella RM, Gammon MD. Improving organochlorine biomarker models for cancer research. Cancer Epidemiol Biomarkers Prev 2005; 14: 2224–36.
  • 23
    Bertazzi PA, Consonni D, Bachetti S, Rubagotti M, Baccarelli A, Zocchetti C, Pesatori AC. Health effects of dioxin exposure: a 20-year mortality study. Am J Epidemiol 2001; 153: 1031–44.
  • 24
    Colt JS, Severson RK, Lubin J, Rothman N, Camann D, Davis S, Cerhan JR, Cozen W, Hartge P. Organochlorines in carpet dust and non-Hodgkin lymphoma. Epidemiology 2005; 16: 516–25.
  • 25
    IARC monographs on the evaluation of carcinogenic risks to humans. Occupational exposures in insecticide application, and some pesticides, 53rd edn., vol. 53. Lyon, France: IARC Press, 1991.
  • 26
    IARC monographs on the evaluation of carcinogenic risks to humans. Some thyrotropic agents, vol. 79. Lyon, France: IARC, 2001.
  • 27
    IARC monographs on the evaluation of carcinogenic risks to humans. Overall evaluations of carcinogenicity: an updating of IARC monographs, 7 edn. ( Suppl.), vol. 1–42. Lyon, France: IARC, 1987.
  • 28
    McConnachie PR, Zahalsky AC. Immune alterations in humans exposed to the termiticide technical chlordane. Arch Environ Health 1992; 47: 295–301.
  • 29
    Daniel V, Huber W, Bauer K, Suesal C, Conradt C, Opelz G. Associations of dichlorodiphenyltrichloroethane (DDT) 4.4 and dichlorodiphenyldichloroethylene (DDE) 4.4 blood levels with plasma IL-4. Arch Environ Health 2002; 57: 541–7.
  • 30
    Reed A, Dzon L, Loganathan BG, Whalen MM. Immunomodulation of human natural killer cell cytotoxic function by organochlorine pesticides. Hum Exp Toxicol 2004; 23: 463–71.
  • 31
    Tryphonas H, Bondy G, Hodgen M, Coady L, Parenteau M, Armstrong C, Hayward S, Liston V. Effects of cis-nonachlor, trans-nonachlor and chlordane on the immune system of Sprague–Dawley rats following a 28-day oral (gavage) treatment. Food Chem Toxicol 2003; 41: 107–18.
  • 32
    Thomas PT. Pesticide-induced immunotoxicity: are Great Lakes residents at risk? Environ Health Perspect 1995; 103 ( Suppl 9): 55–61.
  • 33
    Ezendam J, Staedtler F, Pennings J, Vandebriel RJ, Pieters R, Harleman JH, Vos JG. Toxicogenomics of subchronic hexachlorobenzene exposure in Brown Norway rats. Environ Health Perspect 2004; 112: 782–91.
  • 34
    Hardell L, Lindstrom G, van Bavel B, Hardell K, Linde A, Carlberg M, Liljegren G. Adipose tissue concentrations of dioxins and dibenzofurans, titers of antibodies to Epstein-Barr virus early antigen and the risk for non-Hodgkin lymphoma. Environ Res 2001; 87: 99–107.
  • 35
    Moysich KB, Mendola P, Schisterman EF, Freudenheim JL, Ambrosone CB, Vena JE, Shields PG, Kostyniak P, Greizerstein H, Graham S, Marshall JR. An evaluation of proposed frameworks for grouping polychlorinated biphenyl (PCB) congener data into meaningful analytic units. Am J Ind Med 1999; 35: 223–31.
    Direct Link:
  • 36
    Colt JS, Davis S, Severson RK, Lynch CF, Cozen W, Camann D, Engels EA, Blair A, Hartge P. Residential insecticide use and risk of non-Hodgkin's lymphoma. Cancer Epidemiol Biomarkers Prev 2006; 15: 251–7.
  • 37
    Carpenter DO. Polychlorinated biphenyls (PCBs): routes of exposure and effects on human health. Rev Environ Health 2006; 21: 1–23.
  • 38
    Lu YC, Wu YC. Clinical findings and immunological abnormalities in Yu-Cheng patients. Environ Health Perspect 1985; 59: 17–29.
  • 39
    Nakanishi Y, Shigematsu N, Kurita Y, Matsuba K, Kanegae H, Ishimaru S, Kawazoe Y. Respiratory involvement and immune status in yusho patients. Environ Health Perspect 1985; 59: 31–6.
  • 40
    McFarland VA, Clarke JU. Environmental occurrence, abundance, and potential toxicity of polychlorinated biphenyl congeners: considerations for a congener-specific analysis. Environ Health Perspect 1989; 81: 225–39.
  • 41
    Safe S. Toxicology, structure-function relationship, and human and environmental health impacts of polychlorinated biphenyls: progress and problems. Environ Health Perspect 1993; 100: 259–68.
  • 42
    Silberhorn EM, Glauert HP, Robertson LW. Carcinogenicity of polyhalogenated biphenyls: PCBs and PBBs. Crit Rev Toxicol 1990; 20: 440–96.
  • 43
    Van Den Heuvel RL, Koppen G, Staessen JA, Hond ED, Verheyen G, Nawrot TS, Roels HA, Vlietinck R, Schoeters GE. Immunologic biomarkers in relation to exposure markers of PCBs and dioxins in Flemish adolescents (Belgium). Environ Health Perspect 2002; 110: 595–600.
  • 44
    Hestermann EV, Stegeman JJ, Hahn ME. Relative contributions of affinity and intrinsic efficacy to aryl hydrocarbon receptor ligand potency. Toxicol Appl Pharmacol 2000; 168: 160–72.
  • 45
    Mimura J, Fujii-Kuriyama Y. Functional role of AhR in the expression of toxic effects by TCDD. Biochim Biophys Acta 2003; 1619: 263–8.
  • 46
    Connor K, Safe S, Jefcoate CR, Larsen M. Structure-dependent induction of CYP2B by polychlorinated biphenyl congeners in female Sprague-Dawley rats. Biochem Pharmacol 1995; 50: 1913–20.
  • 47
    Czejkaj P. Phenobarbital-induced expression of cytochrome P450 genes. Acta Biochim Polonica 2000; 47: 1093–105.
  • 48
    Yamada H, Ishii Y, Yamamoto M, Oguri K. Induction of the hepatic cytochrome P450 2B subfamily by xenobiotics: research history, evolutionary aspect, relation to tumorigenesis, and mechanism. Curr Drug Metab 2006; 7: 397–409.
View Full Article (HTML) Get PDF (114K)